A novel, accurate, easy-to-use biomarker test might help flag excessive alcohol use in steatotic liver disease (SLD), ...

News and commentary from the world of gastroenterology and hepatology ...

Research published in the journal Diabetes, Obesity and Metabolism has highlighted that diabetes and obesity are closely ...

The sudden increase in cases of MASLD is a vivid indication of shifting lifestyles across the globe. As the numbers are ...

Metabolic disease is reshaping care delivery and costs, with experts at the Academy of Managed Care Pharmacy (AMCP) 2026 ...

Metabolic liver disease (MASLD) could affect 1.8 billion people by 2050, driven by rising obesity and high blood sugar, a ...

Obesity and associated metabolic diseases, including type 2 diabetes, cardiovascular diseases, and certain cancers, poses ...

Primary liver cancer continues to pose a major global health challenge, ranking as the third leading cause of cancer-related deaths worldwide.

A doctor and dietitian reveal the signs your metabolism is slowing down, plus why this happens and what you can do about it.

Signant Health, the leader in evidence generation for modern clinical trials, announced today the appointment of Dr. Graham C. Ellis as Clinical Vice President. With more than 25 years of experience ...

According to the Care Health Insurance report, liver disease claims have doubled over the past three years, while treatment ...

Brain function has traditionally been interpreted within a neuron-centric framework; however, this view has shifted toward a model of neuron-glia ...